Clinical Trial Update: Pre-Operative Immuno-Modulatory SBRT (POIMS Trial): A Pilot Trial in Early Stage NSCLC [NA]

View source ↗

Summary

The POIMS trial investigating pre-operative immuno-modulatory SBRT in early-stage non-small cell lung cancer has been withdrawn. The study is sponsored by the U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Non-small Cell Lung Cancer | NA | Status: WITHDRAWN